Grupo Medico Camino S.C.
Mexico City, Distrito Federal, Mexico
Research institute in Mexico City
Av. Cuauhtémoc 1251, Sta Cruz Atoyac, Benito Juárez, 03310 Ciudad de México, CDMX
About Grupo Medico Camino S.C.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
10
Hoffmann-La Roche
8
Pfizer
3
Clinical Trials at Grupo Medico Camino S.C.
During the past decade, Grupo Medico Camino S.C. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on
average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-08-31
2016-12-28
Completed
348
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
2013-08-01
2016-04-01
Completed
395
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
2014-02-17
2019-05-20
Completed
686
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer
2015-05-06
2019-02-22
Completed
418
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
2017-08-24
2019-09-04
Completed
566
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
2017-07-12
2029-06-24
Active, not recruiting
5,637
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Grupo Medico Camino S.C."
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Grupo Medico Camino S.C.
According to Clinical.Site data, the most researched conditions in "Grupo Medico Camino S.C." are
"Atopic Dermatitis" (3 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Grupo Medico Camino S.C." in a lesser frequency.
Clinical Trials Intervention Types at Grupo Medico Camino S.C.
Most popular intervention types in "Grupo Medico Camino S.C." are "Drug" (20 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ocrelizumab" (5 trials), "Abemaciclib" (2 trials), "Baricitinib" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Grupo Medico Camino S.C.
The vast majority of trials in "Grupo Medico Camino S.C." are
20 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Grupo Medico Camino S.C.
Currently, there are NaN active trials in "Grupo Medico Camino S.C.".
undefined are not yet recruiting,
8 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Grupo Medico Camino S.C.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Grupo Medico Camino S.C., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".